Advertisement

Topics

Sorin Group Company Profile

21:27 EDT 19th June 2018 | BioPortfolio

Sorin Group (www.sorin.com) is a global, medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3,600 employees worldwide, the Group focuses on three major therapeutic areas that include: cardiopulmonary bypass (extracorporeal circulation and autotransfusion systems), cardiac rhythm management, and heart valve repair and replacement. Every year, over 1 million patients are treated with Sorin Group devices in more than 80 countries.


News Articles [410 Associated News Articles listed on BioPortfolio]

Briefing , PTV News: Feb 18, 2010

FDA rejects GSKL's HorizantFDA approved Sorin's new heart-lung machineJ&J cuts bonuses

Global and North America Artificial Heart Lung Machines Market Status and Future Forecast 20132023 [Report Updated: 05022018] Prices from USD $2500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Global and Europe Defibrillator Market Status and Future Forecast 20132023 [Report Updated: 10012018] Prices from USD $3500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Unlimited Group appoints group managing director

Michael Richards joins the group from VCCP

TMX Group Limited Declares Dividend of $0.50 per Common Share

For the results of the quarter ended December 31, 2017for TMX Group, please click on the following link: http://www.tmx.com/investor-relations/ About TMX Group (TSX:X) TMX Read more...

North 6th Agency Announces N6-Accolades For March 2018

The N6A Cybersecurity & Digital Identity Group took home the "N6A Golden Group" trophy as the highest-performing group for the month. At the end of Read more...

CRP Group Is Ready to Amaze 2018 CES Attendees With Their Innovative Technology

MODENA, Italy, Dec. 28, 2017/PRNewswire/ -- CRP Group along with U.S.-based partner CRP USAand Energica - the sustainable subsidiary of CRP Group Read more...

Predictive Technology Group to Acquire FlagshipHealth Group

Predictive Technology Group, Inc., a provider of data analytics for disease identification and subsequent therapeutic intervention through unique biotechnology treatments has finalized an arrangement ...

PubMed Articles [1822 Associated PubMed Articles listed on BioPortfolio]

Long-term outcomes using the stentless LivaNova-Sorin Pericarbon Freedom™ valve after aortic valve replacement.

Information on the long-term safety, efficacy and durability of third-generation stentless aortic valves is lacking.

Group Influences on Engaging Self-Control: Children Delay Gratification and Value It More When Their In-Group Delays and Their Out-Group Doesn't.

Self-control emerges in a rich sociocultural context. Do group norms around self-control influence the degree to which children use it? We tested this possibility by assigning 3- to 5-year-old childre...

An Examination of Group Size and Valence in Delay Discounting of Shared Outcomes.

Previous research has examined delay discounting in a group context, where the outcomes are shared with others. These studies indicate shallow delay discounting in a group context compared to an indiv...

Ameliorating effects of tempol on methotrexate-induced liver injury in rats.

Methotrexate (MTX) is used in the treatment of certain types of cancers and chronic inflammatory illnesses, although the clinical use of MTX is limited due to its adverse effects, the most common of w...

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Clinical Trials [3706 Associated Clinical Trials listed on BioPortfolio]

Sorin Universal REgistry on Aortic Valve Replacement

Multi-center, International, Prospective, Non comparative, Non randomized, Open label. 5,000 patients to be enrolled approximately worldwide. The objective of this registry is to collect...

Biventricular Tachycardias Outcome Trial

This clinical investigation is a device-based open, prospective, multicenter two-arm randomized trial, comparing patients who are treated in the slow VT zone versus patients who are not tr...

Autologous Platelet-rich Plasma (aPRP) for Complex Aortic Arch Surgerymacrovascular Operation

Perioperative blood loss continues to be a serious problem in complex aortic arch surgery using deep hypothermic circulatory arrest (DHCA). Major blood loss causes increased morbidity and ...

Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair

The purpose of this study is to collect data on the effectiveness and clinical outcomes of the MEMO 3D Annuloplasty ring as used for mitral valve repair.

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Companies [1620 Associated Companies listed on BioPortfolio]

Sorin S.p.A.

Sorin Group (www.sorin.com) is a global company and a leader in the treatment of cardiovascular diseases. The company develops, manufactures and markets medical technologie...

Sorin Group

Sorin Group (www.sorin.com) is a global, medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures and markets med...

DiaSorin Incorporated

DiaSorin, formerly known as INCSTAR, SORIN Diagnostics, and Sienna Biotech along with Alimenterics make up the Medical Systems Group of American Standard Company. Now as one, we provide improved healt...

DiaSorin Inc.

DiaSorin S.p.A. is now a private companyDiaSorin S.p.A. originated as a diagnostic division of Sorin Biomedica S.p.A. and is today a private company that develops and manufactures reagents for in vitr...

LivaNova PLC

LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical devic...

More Information about "Sorin Group" on BioPortfolio

We have published hundreds of Sorin Group news stories on BioPortfolio along with dozens of Sorin Group Clinical Trials and PubMed Articles about Sorin Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sorin Group Companies in our database. You can also find out about relevant Sorin Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record